We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Potential for Metastasis May Be Detected Early

By Biotechdaily staff writers
Posted on 03 Aug 2004
A new study shows the possibility that metatasis is hardwired into normal cells, where doctors can detect whether or not a tumor will spread, long before the patient ever reaches that dangerous phase. More...
The results were reported in the August 3, 2004, issue of the Proceedings of the [U.S.] National Academy of Sciences.

In normal tissues from prostates with metastasizing tumors, researchers at the Pacific Northwest Research Institute (Seattle, WA, USA; www.pnri.org) have found evidence for a DNA structure characteristic of metastasis. The finding poses a challenge to current beliefs about the way cancer develops and spreads. Rare or "rogue” cells may not be breaking away from the tumor and starting new tumors elsewhere, as previously thought. Instead, it appears that the DNA structure for metastasis is actually hardwired into seemingly normal cells that are destined to become metastatic tumor cells.

"Our research is still at an early stage and there is much more to be done,” commented Dr. Donald Malins, of the National Academy of Sciences and lead author of the study. "Early detection is one of the most important tools we have against cancer. To be able to find evidence for a metastasizing tumor even before it reaches that point, well, that would be incredibly valuable--a very powerful new weapon.”




Related Links:
PNRI

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.